August 19, 2017 5:06 PM ET

Biotechnology

Company Overview of Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.

Key Executives for Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.

NameBoard RelationshipsTitleAge
P. Kay Wagoner Ph.D.No Relationships Co-founder, Chief Executive Officer and President68

Icagen, Inc. Prior to Merger with XRpro Sciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Andrew Muratore 9 RelationshipsIcagen, Inc. Prior to Merger with XRpro Sciences, Inc.43
Douglas E. Giordano 39 RelationshipsPfizer Inc.54
Dhiren R. Thakker Ph.D. 21 RelationshipsChesson Laboratory Associates, Inc.--
Roy Swaringen Ph.D. 16 RelationshipsAsymchem Laboratories, Inc.--
John E. Dillberger DVM, Ph.D., DACVP, DABT, FIATP 20 RelationshipsKrenitsky Pharmaceuticals Inc.--
View All Board Members

Icagen, Inc. Prior to Merger with XRpro Sciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$334.2K
334.2K
387.2K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$334.2K
334.2K
18.6M
Compensation as of Fiscal Year 2010
Icagen, Inc. Prior to Merger with XRpro Sciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cellectar Biosciences, Inc. Announces Management Changes
August 18, 2017 9:00 PM ET
Isofol Medical AB (publ) Appoints Sven Erickson as Chief Commercial Officer
August 18, 2017 6:32 PM ET
Kane Biotech Inc. Announces Resignation of Sarah Prichard as Director
August 18, 2017 11:12 AM ET
RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Icagen, Inc. Prior to Merger with XRpro Sciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.